Enhanced intestinal adenomatous polyp formation in Pms2-/-;: Min mice

被引:0
作者
Baker, SM
Harris, AC
Tsao, JL
Flath, TJ
Bronner, CE
Gordon, M
Shibata, D
Liskay, RM
机构
[1] Oregon Hlth Sci Univ, Dept Med & Mol Genet, Portland, OR 97201 USA
[2] Oregon Hlth Sci Univ, Dept Pathol, Portland, OR 97201 USA
[3] Univ Calif Berkeley, Dept Nutr Sci, Berkeley, CA 94720 USA
[4] Univ So Calif, Sch Med, Dept Pathol, Los Angeles, CA 90033 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Analysis of two human familial cancer syndromes, hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis, indicates that mutations in either one of four DNA mismatch repair gene homologues or the adenomatous polyposis coli (APC) gene, respectively, are important for the development of colorectal cancer, To further investigate the role of DNA mismatch repair in intestinal tumorigenesis, we generated mice with mutations in both Ape and the DNA mismatch repair gene, Pms2. Whereas Pms2-deficient mice do not develop intestinal tumors, mice deficient in Pms2 and heterozygous for Min, an allele of Apc, develop approximately three times the number of small intestinal adenomas and four times the number of colon adenomas relative to Alin and Pms2(+/-); Min mice, Although Pms2 deficiency clearly increases adenoma formation in the Min background, histological analysis indicated no clear evidence for progression to carcinoma.
引用
收藏
页码:1087 / 1089
页数:3
相关论文
共 50 条
  • [41] Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice
    Masami Suganuma
    Yasuo Ohkura
    Sachiko Okabe
    Hirota Fujiki
    Journal of Cancer Research and Clinical Oncology, 2001, 127 : 69 - 72
  • [42] Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice
    Suganuma, M
    Ohkura, Y
    Okabe, S
    Fujiki, H
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (01) : 69 - 72
  • [43] The comparative study of acetyl-11-keto-beta-boswellic acid (AKBA) and aspirin in the prevention of intestinal adenomatous polyposis in APC(Min/+) mice
    Wang, Ruiqi
    Wang, Yan
    Gao, Zuhua
    Qu, Xianjun
    DRUG DISCOVERIES AND THERAPEUTICS, 2014, 8 (01) : 25 - 32
  • [44] Fibersol-2 induces apoptosis of Apc-deficient colorectal Cancer (SW480) cells and decreases polyp formation in Apc MIN mice
    Sancho, Sara Cuesta
    Olson, Susan Losee
    So, Eui Young
    Shimomura, Kazuhiro
    Ouchi, Toru
    Preuss, Fabian
    CANCER BIOLOGY & THERAPY, 2016, 17 (06) : 657 - 663
  • [45] Inhibiting EGFR and VEGR reduces small intestinal and colonic polyp formation in a dss enhanced ApcMin/+ mouse model
    Alferez, D.
    Wilkinson, R. W.
    Ryan, A. J.
    Goodlad, R. A.
    GUT, 2008, 57 : A33 - A33
  • [46] Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcΔ716 mice
    Fujishita, Teruaki
    Aoki, Koji
    Lane, Heidi A.
    Aoki, Masahiro
    Taketo, Makoto M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (36) : 13544 - 13549
  • [47] Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice
    Mutoh, M
    Niho, N
    Wakabayashi, K
    BIOLOGICAL CHEMISTRY, 2006, 387 (04) : 381 - 385
  • [48] Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice
    Michaylira, CZ
    Ramocki, NM
    Simmons, JG
    Tanner, CK
    McNaughton, KK
    Woosley, JT
    Greenhalgh, CJ
    Lund, PK
    ENDOCRINOLOGY, 2006, 147 (04) : 1632 - 1641
  • [49] The role of P-glycoprotein in intestinal tumorigenesis:: disruption of mdr1a suppresses polyp formation in ApcMin/+ mice
    Mochida, Y
    Taguchi, K
    Taniguchi, S
    Tsuneyoshi, M
    Kuwano, H
    Tsuzuki, T
    Kuwano, M
    Wada, M
    CARCINOGENESIS, 2003, 24 (07) : 1219 - 1224
  • [50] Concomitant suppression of hyperlipidemia and intestinal polyp formation by a PPAR gamma ligand, pioglitazone, in Apc-deficient mice.
    Mutoh, M
    Niho, N
    Takahashi, M
    Sugimura, T
    Wakabayashi, K
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (11) : 1916S - 1916S